BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 35213254)

  • 1. Epigenetic Inheritance From Normal Origin Cells Can Determine the Aggressive Biology of Tumor-Initiating Cells and Tumor Heterogeneity.
    Feng J; Zhao D; Lv F; Yuan Z
    Cancer Control; 2022; 29():10732748221078160. PubMed ID: 35213254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dualistic origin of human tumors.
    Liu J
    Semin Cancer Biol; 2018 Dec; 53():1-16. PubMed ID: 30040989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal Instability Affects the Tumorigenicity of Glioblastoma Tumor-Initiating Cells.
    Godek KM; Venere M; Wu Q; Mills KD; Hickey WF; Rich JN; Compton DA
    Cancer Discov; 2016 May; 6(5):532-45. PubMed ID: 27001151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
    Shah M; Allegrucci C
    Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer.
    Zhang G; Yang P; Guo P; Miele L; Sarkar FH; Wang Z; Zhou Q
    Biochim Biophys Acta; 2013 Aug; 1836(1):49-59. PubMed ID: 23523716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.
    Pattabiraman DR; Bierie B; Kober KI; Thiru P; Krall JA; Zill C; Reinhardt F; Tam WL; Weinberg RA
    Science; 2016 Mar; 351(6277):aad3680. PubMed ID: 26941323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of cancer stem cell and tumorigenesis.
    Zhu K; Xie V; Huang S
    Adv Cancer Res; 2020; 148():1-26. PubMed ID: 32723561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
    Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K
    Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis.
    Bonnay F; Veloso A; Steinmann V; Köcher T; Abdusselamoglu MD; Bajaj S; Rivelles E; Landskron L; Esterbauer H; Zinzen RP; Knoblich JA
    Cell; 2020 Sep; 182(6):1490-1507.e19. PubMed ID: 32916131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro enrichment of ovarian cancer tumor-initiating cells.
    House CD; Hernandez L; Annunziata CM
    J Vis Exp; 2015 Feb; (96):. PubMed ID: 25742116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells.
    Burns JS; Abdallah BM; Guldberg P; Rygaard J; Schrøder HD; Kassem M
    Cancer Res; 2005 Apr; 65(8):3126-35. PubMed ID: 15833842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoma Stem Cell Heterogeneity.
    Hatina J; Kripnerova M; Houfkova K; Pesta M; Kuncova J; Sana J; Slaby O; Rodríguez R
    Adv Exp Med Biol; 2019; 1123():95-118. PubMed ID: 31016597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prowling wolves in sheep's clothing: the search for tumor stem cells.
    Alkatout I; Kabelitz D; Kalthoff H; Tiwari S
    Biol Chem; 2008 Jul; 389(7):799-811. PubMed ID: 18627316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
    Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
    Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modifications in osteogenic differentiation and transformation.
    Thomas D; Kansara M
    J Cell Biochem; 2006 Jul; 98(4):757-69. PubMed ID: 16598744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging roles of Oct4 in tumor-initiating cells.
    Wang YJ; Herlyn M
    Am J Physiol Cell Physiol; 2015 Dec; 309(11):C709-18. PubMed ID: 26447206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
    Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
    Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of gastrointestinal cancer cells.
    Dewi D; Ishii H; Haraguchi N; Nishikawa S; Kano Y; Fukusumi T; Ohta K; Miyazaki S; Ozaki M; Sakai D; Satoh T; Nagano H; Doki Y; Mori M
    Cancer Sci; 2012 Mar; 103(3):393-9. PubMed ID: 22151786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
    Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
    Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.